News

Published on 11 Feb 2022 on Zacks via Yahoo Finance

Pharma Stock Roundup: PFE, AZN, GSK's Q4 Earnings, FDA Updates for SNY, LLY


Article preview image

This week, Pfizer PFE, AstraZeneca AZN and Glaxo GSK announced fourth-quarter and full-year 2021 results. While the FDA approved Sanofi’s SNY new rare blood disorder medicine, Enjaymo, an FDA advisory committee, voted that Eli Lilly LLY and partner Innovent Biologics conduct an additional study to get approval for their lung cancer candidate, sintilimab, in the United States.

Recap of the Week’s Most Important Stories

Earnings Update: Pfizer’s fourth-quarter results were mixed as it beat estimates for earnings but missed the same for sales. Direct sales and alliance revenues from it and partner BioNTech’s COVID-19 vaccine, Comirnaty, were $12.5 billion in the quarter,

LSE.APH price evolution
NYSE.LLY price evolution
LSE.GSK price evolution
NASDAQ.AZN price evolution
NYSE.GSK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Eli Lilly's (NYSE:LLY) Upcoming Dividend Will Be Larger Than Last Year's

The board of Eli Lilly and Company (NYSE:LLY) has announced that it will be paying its dividend o...

Simply Wall St. via Yahoo Finance 3 Feb 2023

Lilly (LLY) Beats on Q4 Earnings, Lags on Sales, Raises '23 View

Eli Lilly and Company LLY reported fourth-quarter 2022 adjusted earnings per share (EPS) of $2.09...

Zacks via Yahoo Finance 2 Feb 2023

Here’s Why Eli Lilly and Company (LLY) Rose in Q4

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quart...

Insider Monkey via Yahoo Finance 30 Jan 2023

Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod

Eli Lilly and Company LLY announced that the FDA, under an accelerated approval pathway, approved...

Zacks via Yahoo Finance 30 Jan 2023

Why Eli Lilly is tagging the Research Triangle for long-term growth

After a global search, pharmaceutical giant Eli Lilly and Company (NYSE: LLY) selected Research...

American City Business Journals 29 Jan 2023

Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards?

Eli Lilly & Company LLY will report fourth-quarter and full-year 2022 results on Feb 2, before ma...

Zacks via Yahoo Finance 27 Jan 2023

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...

Zacks via Yahoo Finance 26 Jan 2023

Eli Lilly: Far From Dead In Alzheimer's, But Needs Help From Other Areas (NYSE:LLY)

On January 19, Eli Lilly and Company (NYSE:LLY), one of the largest ($329 billion market cap) glo...

Seeking Alpha 26 Jan 2023

Eli Lilly to invest $450 million more to expand diabetes drug plant capacity

The company has been struggling to meet high demand for the drugs Trulicity and Mounjaro, especia...

Reuters 24 Jan 2023

Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance

Eli Lilly and Company LLY and partner Boehringer Ingelheim announced that the FDA has accepted it...

Zacks via Yahoo Finance 23 Jan 2023